Tempus to Present Six Abstracts Accepted at the 2026 Connective Tissue Oncology Society Annual MeetingBusiness Wire • Wednesday
Blood Cancer United Launches REALworld: AML to Accelerate New Treatments for Children with Blood CancerPRNewsWire • Tuesday
SOTERIA Collaborates with Tempus to Advance Precision Oncology for U.S. Military and Veterans Battling CancerPRNewsWire • Monday
Tempus AI: Q3 Strengthens The Platform Thesis, But Cash Returns Still Need To Catch UpSeeking Alpha • 11/08/26
Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge24/7 Wall Street • 11/02/26
Tempus AI's Cancer Screen Business Drives Revenue Up 23%, While a Major Purchase Draws CloserBarrons • 11/02/26
TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now?Zacks Investment Research • 10/30/26
Tempus AI (TEM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 10/26/26
Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor ProfilingBusiness Wire • 10/26/26